Woman in lab working

Project Cure CRC

The Alliance is on a mission to end colorectal cancer. With Project Cure CRC, we’re funding research to make it happen.

doctor with Petri dish

Project Cure CRC addresses an urgent need

Colorectal cancer claims more than 50,000 lives annually in the U.S., with a 13% survival rate for metastatic disease. Despite rising cases in young adults, research funding lags behind, threatening to make CRC the deadliest cancer under 50 by 2030. 

headshot of Michael Sapienza

We initiated Project Cure CRC to make a difference in outcomes for the millions of people affected by this disease, and we are committed to working with experts, industry, and donors to achieve that goal.

Michael Sapienza
CEO, Colorectal Cancer Alliance
Cure CRC Summit podium view

A $100 million commitment

Project Cure CRC is making available tens of millions of dollars to innovators whose work aims to expedite colorectal cancer research to a curable science. 

serum poured in a vial

Innovation is in progress

Project Cure CRC has already invested millions of dollars into promising high-risk/high-reward research. 

Seeking visionaries

Ending colorectal cancer will take broad collaboration. The Alliance seeks supporters and researchers to advance Project Cure CRC. 

Top resources